Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Approvals Action
New formulation painkiller joins register
A Menarini has registered a sublingual formulation of painkiller fentanyl while Janssen has added a new brand of infliximab to the ARTG.
Special Report
How social media is boosting patient power
A number of high-profile campaigns show the growing influence of patients in the social media age.
PBS Top Five
Pain & addiction: a growing market
Pfizer's Lyrica is driving growth in a market that has lately seen the emergence of new drugs and new players although the industry giant is dominant.
Pipeline Monitor
PCSK9 inhibitors push ahead
Praluent and Keytruda hot on the heels of rivals, first malaria vaccine and new ADHD drug.